Assessment of Fecal Glycosylated Mucins as Novel Biomarkers in Inflammatory Bowel Diseases

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

11 Downloads (Pure)

Original language	English
Article number	izac265
Number of pages	2
Journal	Inflammatory Bowel Diseases
Volume	29
Issue number	3
Early online date	10-Jan-2023
DOIs	https://doi.org/10.1093/ibd/izac265
Publication status	Published - Mar-2023

Access to Document

@article{a1c85d5bd2624b788eed6064d32c01e4,

title = "Assessment of Fecal Glycosylated Mucins as Novel Biomarkers in Inflammatory Bowel Diseases",

author = "Sem Geertsema and Otten, {Antonius T.} and Bouwknegt, {Dianne G.} and Visschedijk, {Marijn C.} and Bourgonje, {Arno R.}",

year = "2023",

month = mar,

doi = "10.1093/ibd/izac265",

language = "English",

volume = "29",

journal = "Inflammatory Bowel Diseases",

issn = "1078-0998",

publisher = "LIPPINCOTT WILLIAMS & WILKINS",

number = "3",

}

TY - JOUR

T1 - Assessment of Fecal Glycosylated Mucins as Novel Biomarkers in Inflammatory Bowel Diseases

AU - Geertsema, Sem

AU - Otten, Antonius T.

AU - Bouwknegt, Dianne G.

AU - Visschedijk, Marijn C.

AU - Bourgonje, Arno R.

PY - 2023/3

Y1 - 2023/3

U2 - 10.1093/ibd/izac265

DO - 10.1093/ibd/izac265

M3 - Comment/Letter to the editor

SN - 1078-0998

VL - 29

JO - Inflammatory Bowel Diseases

JF - Inflammatory Bowel Diseases

IS - 3

M1 - izac265

ER -